Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03771820
Title Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors NanoCarrier Co., Ltd
Age Groups: adult | senior
Covered Countries

No variant requirements are available.